Drug intelligence / Profile preview

vitamin k + retinol

Development stage: Unknown
Modality: Small Molecules
Administration: Topical

Overview

A combination of vitamin K (phytonadione) and retinol (vitamin A) used primarily in topical formulations. This combination has been shown to hasten the resolution of laser-induced purpura (bruising) and has beneficial effects on skin health. Vitamin K plays a role in blood coagulation and wound healing, while retinol promotes keratinocyte proliferation and collagen production. Together, they prevent collagen breakdown and stimulate its growth, helping to prevent and repair photodamaged skin.

Other names: vitamin K and retinol ointment1% vitamin K and 0.3% retinol ointment

Targets

F2 (Thrombin)RXRA (Retinoid X receptor alpha)RARA (Retinoic acid receptor alpha)GGCX (Vitamin K-dependent gamma-glutamyl carboxylase)

Beyond the preview

Go deeper on vitamin k + retinol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on vitamin k + retinol.

Explore the full profile